|
contents | america | ||||
| First Annual Hematologic Malignancies Congress in NYC The National Comprehensive Cancer Network (NCCN) will debut a new educational program on September 8: the 1st Annual NCCN Hematologic Malignancies Congress. The event will be held at the Crown Plaza Times Square in New York. Over 100, 000 new cases of hematologic malignancies will be diagnosed in 2006 alone. Important new treatment advances for these diseases have been introduced recently, improving the care available to patients with these blood cancers. As a result, the NCCN is hosting this full-day meeting featuring world-renowned experts who will discuss these clinical advances. These including the integration of the recently FDA approved dasatinib (Sprycel, Bristol-Myers Squibb) in the treatment of chronic myelogenous leukemia and new agents such as lenalidomide (Revlimid, Celgene) in the treatment of multiple myeloma and myelodysplastic syndromes. These changes are all reflected in the NCCN Clinical Practice Guidelines in Oncology, (TM) the recognized standard for clinical policy in the oncology community. These guidelines are updated continually in a consensus-driven process with explicit review of the evidence by multidisciplinary panels of expert physicians from NCCN member institutions. Leaders of these multidisciplinary panels will present important updates to the NCCN guidelines outlining treatment advances, and include Andrew D. Zelenetz, MD, PhD, Memorial Sloan-Kettering Cancer Center and Margaret R. O'Donnell, MD, City of Hope Cancer Center. There will be a media briefing at 11:30 AM, during the meeting, to discuss the NCCN Clinical Practice Guidelines on hematologic malignancies. Several thought leaders from NCCN institutions will focus on the advances that have been made in treating blood cancers and the options that are now available for patients coping with these diseases. Response to the program has been outstanding. The second annual Congress is already planned to be a 2-day event to be held in September, 2007. write your comments about the article :: © 2006 Exhibition News :: home page |